Skip to main content
OpenTrials

Clinical trial condition

Chronic Hand Eczema

Explore clinical trials studying Chronic Hand Eczema. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Chronic Hand Eczema trial results

Completed

Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema

NCT05355818

Conditions
Chronic Hand Eczema
Locations
  • LEO Pharma investigational site Darlinghurst, Australia
  • LEO Pharma investigational site Mitcham, Australia
  • LEO Pharma investigational site Phillip, Australia
  • LEO Pharma investigational site Woolloongabba, Australia
View all 37 locations
View Trial Details
Completed

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

NCT06283550

Conditions
Chronic Hand Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • INNO-6052 Site 12 Fredericton, New Brunswick, Canada
  • INNO-6052 Site 13 Cobourg, Ontario, Canada
  • INNO-6052 Site 11 Montreal, Quebec, Canada
  • INNO-6052 Site 19 Krakow, Poland
View Trial Details
Completed

A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema

NCT06004050

Conditions
Chronic Hand Eczema, Dermatitis, Eczema, +3 more
Locations
  • LEO Pharma Investigational Site Beijing, China
  • LEO Pharma Investigational Site Beijing, China
  • LEO Pharma Investigational Site Beijing, China
  • LEO Pharma Investigational Site Beijing, China
View all 37 locations
View Trial Details
Completed

A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

NCT05259722

Conditions
Chronic Hand Eczema
Locations
  • LEO Pharma Investigational Site Graz, Austria
  • LEO Pharma Investigational Site Linz, Austria
  • LEO Pharma Investigational Site Linz, Austria
  • LEO Pharma Investigational Site Calgary, Canada
View all 102 locations
View Trial Details

Related conditions